chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She used to had very heavy menses with clots prior to covid vaccine #2 after vaccine menses only 2-3 days and light in flow. The period irregularity lasted for six cycles (months) . Are not currently back to normal
This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 34-year-old female subject who was vaccinated with BOOSTRIX, (GlaxoSmithKline). On 11 July 2014, the subject received unspecified dose of BOOSTRIX (.5 ml, intramuscular, unknown injection site). Her last menstrual period was on 16 December 2013 and estimated date of delivery was on 22 September 2014. The subject was exposed to the vaccines during the last trimester. The conception was a normal one (no in-vitro fertilization used). No adverse events were reported. At the time of reporting the pregnancy was ongoing. Follow-up information received on 06 October 2014 from nurse: Some of the patient's details were updated. On 09 September 2014, after 38/7 weeks gestation, the patient gave birth to a live infant, by normal vaginal delivery. The infant had an Apgar score of [9-9], a weight of 8 14.0 lb, a height of 20 inches, a cranial circumference of 13 3/4 inches.
Information has been received from a healthcare worker regarding a patient of unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medication were not reported. On 07-DEC-2018, the patient was vaccinated with improperly stored VARIVAX injection, lot number R009821 with expiration date in 03-APR-2020 which were reconstituted with properly stored sterile diluent (MRK) for prophylaxis (dose, strength and anatomical location not reported). The VARIVAX was stored at a temperature range of -9 degrees Celsius (°C) to 8 °C (2.8C) for the time frame of 37 hours. There was no previous temperature excursion and the call was because of a data logger. No adverse effects reported. This was one of several reports received from the same reporter. Sender's Comments: US-009507513-1812USA010605: US-009507513-1812USA010604: US-009507513-1812USA008007: US-009507513-1812USA010603.
Experiencing Myocarditis symptoms.   sharp pains on back shoulder blade when leaning back, or to side.   pain in heart region in chest area.   Relief from pain when crouching forward.
Mildly sore injection site in my left arm for 48 hours post vaccine; moderate lateral knee pain in both knees 12 to 36 hours post vaccine; moderately swollen lymph node under my left clavicle 4 days post vaccine (currently experiencing); mild confusion and fatigue12-24 hours post vaccine; easily sunburned for just a short time in the sun 18 hours post vaccine (not normal for me); hot flashes 24 to 48 hours post vaccine.
Grandmother stated after VZV given on 9-17-07 in left arm child c/o itching. On 9-18-07 child's left upper arm was red, swollen and still itching. Problem continued to get worse. On 9-19-07 grandmother called here to inform of problems. Stated redness was "about size of coffee cup". Advised to put cool compress on site, given Benadryl and take to MD. On 8-20-07 Grandmother called to inform MD dx of allergic reaction to VCV.
This case was reported by a nurse and described the occurrence of rash in a 60 year old female subject who was vaccinated with hepatitis B vaccine recombinant (Engerix B) for prophylaxis. On 08/29/2005 the subject received 1st dose of Engerix B in the left arm (lot AHBVB135AB). On Sept 4 2005, 6 days after vaccination with Engerix B, the subject experienced a body rash. The subject was seen at a physicians office. The vaccination course with Engerix B was discontinued. The body rash resolved on 9/7/2005. The nurse considered the body rash to possibly be related to vaccination with Engerix B.
This case was reported by a pharmacist via call center representative and described the occurrence of bruising of hand in a 81-year-old female patient who received SHINGRIX (batch number 9AS39, expiry date 13th July 2020). On 8th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 14th May 2018, 6 days after receiving SHINGRIX, the patient experienced bruising of hand. On an unknown date, the outcome of the bruising hand was not recovered/not resolved. The reporter considered the bruising of hand to be possibly related to SHINGRIX. Additional information was received as follows: The patient received SHINGRIX in the left arm. The healthcare professional reported 2 to 3 days before the reporting date (14th May 2018 or 15th May 2018) that the patient developed a bruise on the back of her hand on the same arm where she received the vaccine. Bruise was smaller at first but got larger and on the reporting date, it was covering almost the entire backside of the hand. The patient had no other symptoms.
HOSPITAL COURSE: Patient is an 81-year-old male with history of OSA, hypertension and type 2 diabetes mellitus who presented with cough, sore throat and fever.  In the ED, he was noted to become hypoxemic with ambulation, so was placed on 2 L oxygen.  Chest x-ray showed patchy bibasilar airspace opacities, and COVID-19 testing was positive.  He was admitted to the hospitalist service for further care.   Upon admission, he was started on oral Decadron and IV Remdesivir.  He was able to be weaned off supplemental oxygen over the next 24 hours, and noted improving viral symptoms.   He was felt stable for discharge home on 11/18/22.  He may continue with symptomatic treatment including Tylenol, Tessalon perles and Mucinex.  He should follow-up with his PCP in 1 week.
Whole left arm(not just injection site)throbbing and burning  for  about 3 hours. Lips became numb and tingly and headache started  around 11am . Chills, sweating and body aches started around 4pm.  Fever began around 8pm and reached 102.8 degrees. 6am on 11/4 temperature dropped to  100.1. 10am on 11/4 temperature returned to normal  level.  Some weakness and body aches were still present at that time.
PATIENT REPORTS SHE WOKE UP DAY AFTER VACCINE 8/19/21 WITH HEADACHE/LIGHT HEADEDNESS THAT WENT AWAY AFTER 3 HOURS BUT RECURRED OFF AND ON SINCE VACCINE; PATIENT ALSO REPORTS SHORTNESS OF BREATH DAY AFTER VACCINE 8/19/21 AND THAT GOT NOTICEABLY WORSE 4 DAYS POST VACCINE AND HAS BEEN CONSISTENT SINCE "CANNOT GET A FULL CLEANSING BREATH;" PATIENT ALSO REPORTS RASH DESCRIBED AS DOTS ON TRUNK OF BODY, CHEST, BACK, HIPS, NECK STARTED 8/20/21 AND LASTED UNTIL 8/22/21 GRADUALLY FADING AWAY. THE SHORTNESS OF BREATH IS MOST CONCERNING AS SHE IS A RUNNER AND HAVING TROUBLE WITH CATCHING HER BREATH WITH REGULAR ACTIVITIES.
Patient reported dizziness 15 minutes after vaccination administration and rash, hives, lethargy, dizziness, and swollen lymph nodes within 24 hours and continuing for 48 hours.
shingles/ possible Shingles on date of vaccination; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) (batch number 3L794, expiry date 21st September 2021) for prophylaxis.   On 4th June 2019, the patient received the 1st dose of Shingrix. On 4th June 2019, less than a day after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist inquired that was there any side effects to patient who received Shingrix and had Shingles. The health care professional stated that patient received a dose of Shingrix and the patient thought he had Shingles. The health care professional stated that they did not  know if patient had or not.
5 minutes after the shot, a feeling of warmth went through my upper body to my head & my tongue was tingling. It lasted about 30 seconds.  It happened again about 1/2 hour later (11:12 am) but not as strong or as long.
April 2, 2021  1st dose at 10:45 AM  Bloody nose at 1:00 PM April 4, 2021  Bloody nose at 11:00 AM  Migraine headache 1:00 PM April 7, 2021  Migraine headache 11:00 AM* April 10, 2021  Migraine headache 2:30 PM* April 17, 2021  Migraine headache 10:00 AM* April 21, 2021  Migraine headache 2:30 PM* April 23, 2021  2nd dose at 11:15 AM April 25, 2021  Sore muscles in groin area begin April 26, 2021  Sore muscles in groin area continue April 27, 2021   Sore muscles in groin area continue April 28, 2021  Sore muscles in groin area continue  Soreness in butt muscles begins April 29,2021  Sore muscles in groin area continue  Sore butt muscles worsen April 30, 2021  Sore muscles in groin area continue  Sore butt muscles continue May 1, 2021  Sore muscles in groin area continue  Sore butt muscles continue  Pins and needles sensation in left hand  May 2, 2021 Through May 15, 2021  Sore muscles in groin area continue  Sore butt muscles continue May 16, 2021  Sore muscles in groin area continue  Sore butt muscles continue  Sore upper arm muscles both arms begins May 17, 2021 to May 30, 2021  Sore muscles in groin area continue  Sore butt muscles continue  Sore muscles in upper arms continues May 31, 2021  Sore muscles in groin area continue  Sore butt muscles continue  Sore muscles in upper arms continues  Pins and needles sensation in left hands begins June 1st through June 16, 2021  Sore muscles in groin area continue  Sore butt muscles continue  Sore muscles in upper arms continues generally worsening         Pins and needles sensation in left hand continues; becomes 100% of the time for thumb  June 17, 2021  Sore muscles in groin area continue  Sore butt muscles continue  Sore muscles in upper arms continues  Pins and needles sensation in left hand continues; 100% of the time for thumb  Steroid shot at 2:30 PM June 18, 2021         Steroid shat has relieved 95% of muscle pain and 50% of pins and needles sensations. June 19 through 21, 2021         Pain relief from the steroid shot has gradually reduced.
Stinging Pain when injected Pain in left upper arm when injected Both went away in 2 minutes  At 10:00 pm became cold. No fever. Arm sore at sight.   No fever.  Went to bed with one 250 mg Tylenol and heating pad. Woke up this morning, no chills. Still have sore arm.  Feeling somewhat lethargic but fine.
The first vaccine I had a headache for 2 days. The second vaccine: By 9pm the same night i had a migraine Saturday 9/25 I woke up with upper back pain and a headache Sunday 9/26 i had the same symptoms and also woke up with a swollen lymph node in my left armpit and had armpit pain.  Monday and Tuesday I continued to have all 3 symptoms.. Tuesday night 9/28 around 7pm I started having stomach cramping  Wednesday 9/29 I woke up with an upset stomach and had diarrhea  as well as back pain.
I was 4 months pregnant at first vaccine. 12/2022 5 months pregnant at second dose 1/2022  Completely normal anatomy scan at 20 weeks gestation and completely normal scans at perinatology on 12/27/2022  At 6 months pregnant I became severely preeclamptic and with SEVERE IUGR. Symptoms started on 2/7/2022 and I was hospitalized on 2/9/2022 with delivery scheduled due to severity of preeclampsia.   I have had a prior pregnancy with NO complications. I meet ZERO risk factors for preeclampsia.   I had to deliver my daughter at 25 weeks gestation via Csection  in which she passed away 6 hours later. She was 404grams. Placenta was sent for testing and many complications related to placenta in which were not seen on any prior scans prior to vaccines.   Estimated due date was 5/22/2022. Severe prematurity and IUGR as diagnosis on death certificate.
Sudden onset of vertigo with headache; saw a DPT with expertise in treatment of vertigo; saw her on the third day and it was fixed
This spontaneous report was received from a 68 year old female patient, who was reporting on herself. The patient's pertinent medical history included high blood pressure and insomnia. She was allergic to codeine and penicillin. On 21-OCT-2015, the patient was vaccinated with a dose of ZOSTAVAX subcutaneously (dose, lot# and expiration date were not reported). The patient's concomitant medications included unspecified blood pressure medication. On 21-OCT-2015, after receiving ZOSTAVAX, the patient experienced swelling at the injection site and bumpy rash. The patient sought medical attention, she talked with pharmacist. No treatment was given to the patient for the events and no lab diagnostic studies were performed. The outcomes of the events were reported as not recovered. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Muscle spasms; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Muscle spasms). At the time of the report, MUSCLE SPASMS (Muscle spasms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported.
patient experience pain in arm and described the pain as shooting pain down her arm to her fingers; patient experience pain in arm and described the pain as shooting pain down her arm to her fingers; redness at the injection site; Indication: "chronic lung disease"; This spontaneous report was received from a pharmacist referring to a 44 year old female patient with asthma and a drug reaction/allergy to sulfa. Patient's pertinent medical history was not provided. Concomitant therapies included estradiol, ethinyl estradiol (+) ferrous fumarate (+) norethindrone acetate (BLISOVI FE), mometasone furoate (ASMANEX HFA) and prednisone.       On 30-SEP-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot # S029542, expiration date on 10-JUN-2021, by intramuscular route, for chronic lung disease. On this same vaccination date, patient experienced pain in her arm (pain in extremity) which was described as a shooting pain (pain) down her arm to her fingers. Additionally, she also started to experience redness at the injection site (injection site erythema). No treatment was given for the adverse experiences and no medical attention was sought. It was unknown if any laboratory study was performed.  At reporting time, patient was recovering from the adverse experiences and causality assessment between all events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S029542; expirationdate: 10-JUN-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Patient did not have any listed events as of yet. She was expecting shingles and got a covid vaccine. She did already  have both moderna doses, this would be dose 3 for her as a pfizer. Upon investigating, I did see that the CDC has okayed the mixing of pfizer and moderna at last resort so we do not intend the patient to experience any adverse effects. Followed through with shingles shot as scheduled.
I believe that I received an incorrect dose for my first COVID vaccine dose I asked the administering person how much was being injected, and I heard 0.25mL ("point two five mL") I saw the syringe, and I thought it looked like that amount (I'm a PhD scientist and trained to know what volumes look like in various size syringes) Today when I got my second dose (5/11/2021), the syringe looked larger, and I saw on my exit report from CVS that I was given 0.5mL, which led me to question whether the first and second doses were supposed to be different I saw that both Moderna doses were to be 0.5mL, and I called the pharmacy to ask about this  He said that Moderna has always been 0.5mL and suggested that maybe I heard wrong  I'm a scientist and am trained to know what various volumes look like in a syringe I could be wrong, but I could have sworn he said 0.25mL for my first dose, so I wanted to make a report of this, just in case
I had a low grade fever with chills and completely lethargic. Soon after, I had a herpes outbreak.
Received first Covid 19 vax (Moderna) on 2/19/21. Arm a little sore after but cleared up after a day or so. Around day 10 she woke up in the morning with a large area of redness, warmth, and swelling at the injection site - sought medical care and they told her it was "Covid Arm" and treated her for infection/cellulitis with an antibiotic "c something"  As of 3/19 when she came in for second dose the arm was starting to resolve but not completely resolved yet. Vax given in Left Arm instead, and she stated this was also recommended by her doctor.
heart attack- like symptoms; Diagnosis was severe reaction to the shot which later led to vision problems such as floaters, swelling etc.; Diagnosis was severe reaction to the shot which later led to vision problems such as floaters, swelling etc.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the parent.  A 27-year-old male patient received BNT162b2 (BNT162B2), in May2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. If other vaccine in four weeks and other medications in two weeks were reported as unknown. If covid prior vaccination Unknown. If covid tested post vaccination Unknown. Known allergies unknown. Other medical history unknown. Facility type vaccine Pharmacy or Drug Store. The following information was reported: VITREOUS FLOATERS (hospitalization, disability), SWELLING (hospitalization, disability) all with onset May2021, outcome "not recovered" and all described as "Diagnosis was severe reaction to the shot which later led to vision problems such as floaters, swelling etc."; MYOCARDIAL INFARCTION (hospitalization, disability, medically significant) with onset May2021, outcome "not recovered", described as "heart attack- like symptoms". The events "heart attack- like symptoms" and "diagnosis was severe reaction to the shot which later led to vision problems such as floaters, swelling etc." required emergency room visit. It was unknown if therapeutic measures were taken as a result of myocardial infarction, vitreous floaters, swelling. It was reported that, adverse event the family lives in (place withheld) and the son received the vaccine from (name withheld) in (place withheld) last year and then proceeded to have heart attack- like symptoms. The father was summoned and took his son to the hospital. Diagnosis was severe reaction to the shot which later led to vision problems such as floaters, swelling etc. The hospital people were perplexed and not really sure why this happened and could only attend to symptoms. The son lives with the parents and is not able to work and still has symptoms. Adverse event resulted in [Emergency room/department or urgent care, Disability or permanent damage]. If treatment adverse events unknown.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from a certified medical assistant (C.M.A.) concerning a 13 year old female patient who on 06-AUG-2007 was vaccinated with a second dose of Gardasil lot #657868/0523U.  The reporter mentioned that patient developed an extended menstrual period after vaccination with the second dose of Gardasil.  No further information known at this time.  Patient's mother contacted the doctor's office for the event.  The outcome was unknown.  Additional information has been requested.
Became unable to take care of her daily activities, unable to remember anything and when she passed away we found that none of her bills had been paid since before she took her 2nd shot.  She was disoriented, confused, didn't know where she was or remember speaking with anyone on the phone and just felt overall worse.  Since she had the chronic health issues she/we were not aware she had gotten worse as she pulled away from everyone and kept telling us "this episode was just lasting longer".  When she passed and I started going through her things I realized it all started after the shot.  Nothing had been taken care of after that date.  She also had been driving up until March, she herself stopped driving stating she didn't feel comfortable in driving any longer.
This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions/allergies and concomitant medications was not reported. On 01-DEC-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, "10PK-0.5ml SD-PFS LLok wTip" which had the lot # K009874 with expiration date 19-MAR-2016, (dosage number and route of administration were not reported). Nonetheless, no adverse effects were reported and no product quality complaint was involved. On unspecified dates, the vaccine experienced two temperature excursions one of 48 hours and other of 40 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius) and the highest recorded temperature was 47 F (8.333333333 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". This is one of the several reports received from the same reporter. Additional information has been requested.